Table 1.
Demographical and neurological data.
| Length of illness (days) | Etiology | Age/gender | Neurological examination |
Anosognosia |
Position sense | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| V | SS | M | V | SS | M | ||||||
| N− | P1 | 17 | T + H | 41/F | − | − | + | − | − | − | 0 |
| N− | P2 | 15 | T | 55/M | − | − | − | − | − | − | 1 |
| N− | P3 | 58 | A + H | 63/F | NA | NA | NA | NA | NA | NA | 0 |
| N− | P4 | 15 | I | 43/F | − | E | + | − | − | − | 2 |
| N− | P5 | 38 | I | 52/F | − | − | + | − | − | − | NA |
| N− | P6 | 33 | I | 53/M | − | E | + | − | − | − | 3 |
| N− | P7 | 30 | I | 66/F | − | E | + | − | − | − | 0 |
| N− | P8 | 32 | I | 78/F | E | ++ | ++ | − | + | + | 7 |
| N− | P9 | 17 | H | 57/F | − | E | ++ | − | − | − | 6 |
| N+ | P10 | 47 | I + H | 97/F | ++ | + | ++ | ++ | ++ | ++ | NA |
| N+ | P11 | 128 | H | 73/F | ++ | + | ++ | + | + | ++ | 11 |
| N+ | P12 | 32 | I + H | 51/F | ++ | ++ | ++ | + | + | + | 10 |
| N+ | P13 | 26 | I | 60/M | ++ | − | ++ | + + | − | − | 7 |
| N+ | P14 | 547 | T | 30/M | ++ | ++ | ++ | − | − | − | 12 |
| N+ | P15 | 40 | H + T | 70/F | ++ | ++ | ++ | + | + | − | NA |
| N+ | P16 | 23 | TBI | 60/M | ++ | ++ | ++ | − | − | − | 19 |
Etiology: I/H/A/T/TBI, ischemic/hemorrhagic/aneurysm/tumor/traumatic brain injury. Neurological examination: M/SS/V, motor/somatosensory/visual half-field deficits contralateral to the damaged hemisphere. Anosognosia: M/SS/V, for motor/somatosensory/visual half-field deficits. e, extinction to double simultaneous stimulation (for visual and somatosensory deficits); ++/+, severe/moderate deficit; −, no deficit; NA, not available. Position sense: n° errors out of 40 trials. N−, patients without USN; N+, patients with USN.